Garlic allicin as a potential agent for controlling oral pathogens

Journal of Medicinal Food

Volumn 14, Issue 11, 2011, Pages 1338-1343

  Bachrach, Gilad ^a   Jamil, Areen ^a   Naor, Ronit ^a   Tal, Golan ^b   Ludmer, Zvi ^b   Steinberg, Doron ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

allicin; caries; garlic; periodontitis

Indexed keywords

ALLICIN; ANTIINFECTIVE AGENT; ARGININE; BENZOYLARGININE 4 NITROANILIDE; LYSINE; PROTEINASE; VIRULENCE FACTOR;

ACTINOMYCES; ACTINOMYCES ORIS; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BIOFILM; BROTH DILUTION; CHRONIC DISEASE; CONFOCAL LASER MICROSCOPY; DENTAL CARIES; DRUG SENSITIVITY; FUSOBACTERIUM NUCLEATUM; GARLIC; NONHUMAN; PERIODONTITIS; PLANKTON; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; STAINING; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SOBRINUS; ZYMOGRAPHY;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADHESINS, BACTERIAL; ANTI-INFECTIVE AGENTS; ARGININE; BIOFILMS; CYSTEINE ENDOPEPTIDASES; DENTAL CARIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FUSOBACTERIUM NUCLEATUM; GARLIC; LYSINE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, CONFOCAL; PLANT EXTRACTS; PORPHYROMONAS GINGIVALIS; STREPTOCOCCUS MUTANS; SULFINIC ACIDS;

ACTINOMYCES; ALLIUM SATIVUM; BACTERIA (MICROORGANISMS); FUSOBACTERIUM NUCLEATUM; NEGIBACTERIA; PORPHYROMONAS GINGIVALIS; POSIBACTERIA; STREPTOCOCCUS MUTANS;

EID: 80052721620     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2010.0165     Document Type: Article

References (30)

1. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr.: Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144. (Pubitemid 128705944)
2. Kolenbrander PE, Palmer RJ Jr., Periasamy S, Jakubovics NS: Oral multispecies biofilm development and the key role of cellcell distance. Nat Rev Microbiol 2010;8:471-480.
3. Haffajee AD, Socransky SS, Gunsolley JC: Systemic antiinfective periodontal therapy. A systematic review. Ann Periodontol 2003;8:115-181.
4. Haffajee AD, Torresyap G, Socransky SS: Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol 2007;34:243-253.
5. Haffajee AD, Patel M, Socransky SS: Microbiological changes associated with four different periodontal therapies for the treatment of chronic periodontitis. Oral Microbiol Immunol 2008;23:148-157. (Pubitemid 351248610)
6. Liu PF, Zhu WH, Huang CM: Vaccines and photodynamic therapies for oral microbial-related diseases. Curr Drug Metab 2009;10:90-94.
7. Ali M, Bordia T, Mustafa T: Effect of raw versus boiled aqueous extract of garlic and onion on platelet aggregation. Prostaglandins Leukot Essent Fatty Acids 1999;60:43-47. (Pubitemid 29182164)
8. Hann G, Koch PH: History, folk medicine, and legendary uses of garlic. Garlic: The Science and Therapeutic Application of Allium Sativum L. and Related Species. Baltimore, Lippincott Williams & Wilkins, 1996, pp 37-107.
9. Harris JC, Cottrell SL, Plummer S, Lloyd D: Antimicrobial properties of Allium sativum (garlic). Appl Microbiol Biotechnol 2001;57:282-286. (Pubitemid 32972334)
10. Block E: Garlic and Other Alliums: The Lore and the Science. Cambridge, United Kingdom, Royal Society of Chemistry, 2010.
11. WHO monographs on selected medicinal plant. World Health Organization. 1999. http://whqlibdoc.who.int/publications/1999/ 9241545178.pdf (accessed Mar 2011).
12. Groppo FC, Ramacciato JC, Simoes RP, Florio FM, Sartoratto A: Antimicrobial activity of garlic, tea tree oil, and chlorhexidine against oral microorganisms. Int Dent J 2002;52:433-437.
13. Cavallito CJ, Bailey JH: Allicin, the antibacterial principle of Allium sativum. Isolation, physical properties and antibacterial action. J Am Chem Soc 1944;66:1950-1951.
14. Ankri S, Mirelman D: Antimicrobial properties of allicin from garlic. Microbes Infect 1999;1:125-129.
15. Rabinkov A, Miron T, Konstantinovski L, Wilchek M, Mirelman D et al.: The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim Biophys Acta 1998;1379:233-244. (Pubitemid 28252900)
16. Gupta KC, Viswanathan R: Combined action of streptomycin and chloramphenicol with plant antibiotics against tubercle bacilli. I. Streptomycin and chloramphenicol with cepharanthine. II. Streptomycin and allicin. Antibiot Chemother 1955;5:24-27.
17. Bakri IM, Douglas CW: Inhibitory effect of garlic extract on oral bacteria. Arch Oral Biol 2005;50:645-651. (Pubitemid 40689535)
18. Lawson LD, Wood SG, Hughes BG: HPLC analysis of allicin and other thiosulfinates in garlic clove homogenates. Planta Med 1991;57:263-270.
19. Miron T, Bercovici T, Rabinkov A, Wilchek M, Mirelman D: [(3)H]Allicin: preparation and applications. Anal Biochem 2004;331:364-369.
20. Henssge U, Do T, Radford DR, et al.: Emended description of Actinomyces naeslundii and descriptions of Actinomyces oris sp. nov. and Actinomyces johnsonii sp. nov., previously identified as Actinomyces naeslundii genospecies 1, 2 and WVA 963. Int J Syst Evol Microbiol 2009;59:509-516.
21. Shi Y, Ratnayake DB, Okamoto K, et al.: Genetic analyses of proteolysis, hemoglobin binding, and hemagglutination of Porphyromonas gingivalis. Construction of mutants with a combination of rgpA, rgpB, kgp, and hagA. J Biol Chem 1999;274: 17955-17960.
22. Altman H, Steinberg D, Porat Y, et al.: In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria. J Antimicrob Chemother 2006;58:198-201. (Pubitemid 44295008)
23. Ankri S, Miron T, Rabinkov A, Wilchek M, Mirelman D: Allicin from garlic strongly inhibits cysteine proteinases and cytopathic effects of Entamoeba histolytica. Antimicrob Agents Chemother 1997;41:2286-2288. (Pubitemid 27422229)
24. Holt SC, Bramanti TE: Factors in virulence expression and their role in periodontal disease pathogenesis. Crit Rev Oral Biol Med 1991;2:177-281.
25. Curtis MA, Aduse Opoku J, et al.: Attenuation of the virulence of Porphyromonas gingivalis by using a specific synthetic Kgp protease inhibitor. Infect Immun 2002;70:6968-6975. (Pubitemid 35387932)
26. Kadowaki T, Yamamoto K: Suppression of virulence of Porphyromonas gingivalis by potent inhibitors specific for gingipains. Curr Protein Pept Sci 2003;4:451-458. (Pubitemid 37455914)
27. Liberio SA, Pereira AL, Araujo MJ, et al.: The potential use of propolis as a cariostatic agent and its actions on mutans group streptococci. J Ethnopharmacol 2009;125:1-9.
28. Genco CA, Potempa J, Mikolajczyk-Pawlinska J, Travis J: Role of gingipains R in the pathogenesis of Porphyromonas gingivalismediated periodontal disease. Clin Infect Dis 1999;28:456-465. (Pubitemid 29242518)
29. Grenier D, Roy S, Chandad F, et al.: Effect of inactivation of the Arg- and/or Lys-gingipain gene on selected virulence and physiological properties of Porphyromonas gingivalis. Infect Immun 2003;71:4742-4748. (Pubitemid 36919943)
30. Boisvert H, Duncan MJ: Translocation of Porphyromonas gingivalis gingipain adhesin peptide A44 to host mitochondria prevents apoptosis. Infect Immun;78:3616-3624.